MOREPEN LABORATORIES Financial Statement Analysis
|
||
The Revenues of MOREPEN LABORATORIES have increased by 7.17% YoY .
The Earnings Per Share (EPS) of MOREPEN LABORATORIES has increased by 14.36 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
MOREPEN LABORATORIES Last 5 Annual Financial Results
[BOM: 500288|NSE : MOREPENLAB]
Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|---|
Revenues | ₹1,812 Cr | ₹1,690 Cr | ₹1,418 Cr | ₹1,547 Cr | ₹1,188 Cr |
Expenses | ₹1,638 Cr | ₹1,532 Cr | ₹1,338 Cr | ₹1,410 Cr | ₹1,070 Cr |
Operating Profit (Excl OI) | ₹174 Cr | ₹159 Cr | ₹80 Cr | ₹137 Cr | ₹119 Cr |
Other Income | ₹18 Cr | ₹14 Cr | ₹6.13 Cr | ₹20 Cr | ₹12 Cr |
Interest | ₹8.34 Cr | ₹3.71 Cr | ₹1.98 Cr | ₹2.43 Cr | ₹1.79 Cr |
Depreciation | ₹29 Cr | ₹33 Cr | ₹28 Cr | ₹28 Cr | ₹30 Cr |
Profit Before Tax | ₹155 Cr | ₹135 Cr | ₹56 Cr | ₹127 Cr | ₹99 Cr |
Profit After Tax | ₹118 Cr | ₹97 Cr | ₹39 Cr | ₹102 Cr | ₹97 Cr |
Consolidated Net Profit | ₹118 Cr | ₹96 Cr | ₹39 Cr | ₹102 Cr | ₹97 Cr |
Earnings Per Share (Rs) | ₹2.15 | ₹1.88 | ₹0.76 | ₹2.13 | ₹2.16 |
PAT Margin (%) | 6.51 | 5.72 | 2.73 | 6.57 | 8.17 |
ROE(%) | 11.78 | 12.08 | 5.93 | 21.79 | 29.20 |
ROCE(%) | 15.48 | 16.82 | 8.40 | 24.86 | 27.13 |
Total Debt/Equity(x) | 0.07 | 0.03 | 0.03 | 0.03 | 0.04 |
Key Financials |
||
Market Cap | : | ₹ 2,587.7 Cr |
Revenue (TTM) | : | ₹ 1,781.6 Cr |
Net Profit(TTM) | : | ₹ 93.3 Cr |
EPS (TTM) | : | ₹ 1.7 |
P/E (TTM) | : | 27.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
MOREPEN LABORATORIES | -5.2% | -25.1% | -21% |
SUN PHARMACEUTICAL INDUSTRIES | 2.6% | -5.1% | -6.4% |
DIVIS LABORATORIES | -0.5% | -10.1% | 21.8% |
CIPLA | 4.7% | 4.8% | -4.1% |
TORRENT PHARMACEUTICALS | 0.6% | 5.2% | 8.6% |
DR REDDYS LABORATORIES | 4.3% | -0.7% | -11.4% |
MANKIND PHARMA | -3% | -7% | 13% |
ZYDUS LIFESCIENCES | 4.6% | 2.3% | -23.5% |
LUPIN | 2.2% | 1.9% | -7.4% |
MOREPEN LABORATORIES Revenues
[BOM: 500288|NSE : MOREPENLAB]
Y-o-Y | 7.17 % |
5 Yr CAGR | 11.12 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹1,812 Cr | 7.17 | |
Mar2024 | ₹1,690 Cr | 19.25 | |
Mar2023 | ₹1,418 Cr | -8.36 | |
Mar2022 | ₹1,547 Cr | 30.20 | |
Mar2021 | ₹1,188 Cr | - |
MOREPEN LABORATORIES Operating Profit
[BOM: 500288|NSE : MOREPENLAB]
Y-o-Y | 9.74 % |
5 Yr CAGR | 10.09 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹174 Cr | 9.74 | |
Mar2024 | ₹159 Cr | 99.45 | |
Mar2023 | ₹80 Cr | -41.81 | |
Mar2022 | ₹137 Cr | 15.32 | |
Mar2021 | ₹119 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 2.45 % |
5 Yr CAGR | -0.94 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 9.61% | 2.45 | |
Mar2024 | 9.38% | 67.20 | |
Mar2023 | 5.61% | -36.54 | |
Mar2022 | 8.84% | -11.42 | |
Mar2021 | 9.98% | - |
MOREPEN LABORATORIES Profit After Tax
[BOM: 500288|NSE : MOREPENLAB]
Y-o-Y | 22.73 % |
5 Yr CAGR | 5.00 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹118 Cr | 22.73 | |
Mar2024 | ₹96 Cr | 148.64 | |
Mar2023 | ₹39 Cr | -61.97 | |
Mar2022 | ₹102 Cr | 4.73 | |
Mar2021 | ₹97 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 13.81 % |
5 Yr CAGR | -5.52 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 6.51 % | 13.81 | |
Mar2024 | 5.72 % | 109.52 | |
Mar2023 | 2.73 % | -58.45 | |
Mar2022 | 6.57 % | -19.58 | |
Mar2021 | 8.17 % | - |
MOREPEN LABORATORIES Earnings Per Share (EPS)
[BOM: 500288|NSE : MOREPENLAB]
Y-o-Y | 14.36 % |
5 Yr CAGR | -0.12 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹2.15 | 14.36 | |
Mar2024 | ₹1.88 | 147.37 | |
Mar2023 | ₹0.76 | -64.32 | |
Mar2022 | ₹2.13 | -1.39 | |
Mar2021 | ₹2.16 | - |
MOREPEN LABORATORIES Return on Capital Employed (ROCE)
[BOM: 500288|NSE : MOREPENLAB]
Y-o-Y | -7.97 % |
5 Yr CAGR | -13.09 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 15.48% | -7.97 | |
Mar2024 | 16.82% | 100.24 | |
Mar2023 | 8.4% | -66.21 | |
Mar2022 | 24.86% | -8.37 | |
Mar2021 | 27.13% | - |
MOREPEN LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹47.2 |
Current MarketCap | : | ₹ 2,587.7 Cr |
Updated EOD on | : | Aug 13,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | -5.2% |
-25.1% |
-21% |
SENSEX | -0% |
-2.1% |
1.1% |
MOREPEN LABORATORIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE HEALTHCARE | 2.7% | -0.5% | 8.6% |
BSE SMALLCAP | -0.3% | -4.9% | -2.8% |
You may also like the below Video Courses
FAQ about MOREPEN LABORATORIES Financials
How the annual revenues of MOREPEN LABORATORIES have changed ?
The Revenues of MOREPEN LABORATORIES have increased by 7.17% YoY .
How the Earnings per Share (EPS) of MOREPEN LABORATORIES have changed?
The Earnings Per Share (EPS) of MOREPEN LABORATORIES has increased by 14.36 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs